MAIA insider trading news
Large insider purchases and sales at MAIA, from SEC Form 4 filings.
-
MAIA Biotechnology, Inc. director Stan Smith buys 100,000 shares worth $100,000
An open-market purchase between Nov 13 and Nov 16, reported to the SEC on Nov 17.
-
MAIA Biotechnology, Inc. CEO Vlad Vitoc purchases $100,000 in stock
After the purchase, the filing lists 1,149,121 shares held.